Nicholas T. Karanikolas, MD, FACS

Background and Expertise:

Dr. Karanikolas is an outstanding Urological Oncologist who brings his extensive clinical experience to our resident rotation at the VA New York Harbor Healthcare System in Brooklyn where he serves as Chief of Urology. His research centers on outcomes of PSA screening and prostate biopsy in the Veterans population.

Education:

• 1994 - 1998: Doctor of Medicine, SUNY Downstate Medical School Brooklyn, NY

• 1988 - 1992: B.A. Biology, New York University, New York, NY

Training:

• 2004 - 2006: Fellowship in Urologic Oncology in the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY
• 2000 - 2004: Resident in the Department of Urology , SUNY Downstate School of Medicine, Brooklyn, NY

• 1998 - 2000: Resident in the Department of Surgery, SUNY Downstate, School of Medicine, Brooklyn, NY

• Rates of Clinically Significant Prostate Cancer in African Americans Increased Significantly Following the 2012 U.S. Preventative Services Task Force Recommendation Against Prostate Specific Antigen Screening: A Single Institution Retrospective Study.
  Arace J, Flores V, Monaghan T, Robins D, Karanikolas N, Winer A, Weiss J.Int J Clin Pract. 2019 Nov 21:e13447. doi: 10.1111/ijcp.13447. [Epub ahead of print]PMID: 31750596
• The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis.
  Pantelidis P, Tsitsopoulos PP, Pappa E, Theologou E, Karanikolas N, Drosos C, Tsonidis C. Clin Neurol Neurosurg. 2019 Sep;184:105450. doi: 10.1016/j.clineuro.2019.105450. Epub 2019 Jul 18.PMID:31376773
• The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
  Verges DP, Dani H, Sterling WA, Weedon J, Atallah W, Mehta K, Schreiber D, Weiss JP, Karanikolas NT.J Natl Med Assoc. 2017 Spring;109(1):49-54. doi: 10.1016/j.jnma.2016.09.001. Epub 2016 Sep 23.PMID: 28259216
• Neoadjuvant concurrent chemoradiation for curative treatment of penile squamous cell carcinoma.
  Chhabra A, Schwartz D, Leaf A, Karanikolas N, Weiss JP, Schreiber D.Case Rep Oncol Med. 2014;2014:479376. doi: 10.1155/2014/479376. Epub 2014 Oct 7.PMID: 25400960
• Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database.
  Schreiber D, Rineer J, Weiss J, Leaf A, Karanikolas N, Rotman M, Schwartz D.Am J Clin Oncol. 2013 Apr;36(2):126-31. doi: 10.1097/COC.0b013e3182438c71.PMID: 22391430
• Optimizing prostate cancer detection during biopsy by standardizing the amount of tissue examined per core.
  Sfakianos JP, Thorner DA, Dovirak O, Weiss JP, Karanikolas NT.BJU Int. 2011 Nov;108(10):1578-81. doi: 10.1111/j.1464-410X.2011.10239.x. Epub 2011 May 31.PMID: 21627750
• Rate of renal cell carcinoma subtypes in different races.
  Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N.Int Braz J Urol. 2011 Jan-Feb;37(1):29-32;discussion 33-4.PMID: 21385477
• Segmental renal artery pseudoaneurysm after partial nephrectomy.
  Sfakianos JP, Thorner DA, Sullivan RA, Karanikolas NT.J Urol. 2011 Jan;185(1):281-2. doi: 10.1016/j.juro.2010.09.053. No abstract available.  PMID: 21075391
• Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients.
  Bochner BH, Karanikolas N, Barakat RR, Wong D, Chi DS.J Urol. 2009 Nov;182(5):2376-80. doi: 10.1016/j.juro.2009.07.038. Epub 2009 Sep 16.PMID: 19762044
• Survival rates after resection for localized kidney cancer: 1989 to 2004.
  Russo P, Jang TL, Pettus JA, Huang WC, Eggener SE, O'Brien MF, Karellas ME, Karanikolas NT, Kagiwada MA.Cancer. 2008 Jul 1;113(1):84-96. doi: 10.1002/cncr.23520.PMID: 18470927
• The anterior layer of Denonvilliers' fascia: a common misconception in the laparoscopic prostatectomy literature.
  Secin FP, Karanikolas N, Gopalan A, Bianco FJ, Shayegan B, Touijer K, Olgac S, Myers RP, Dalbagni G, Guillonneau B.J Urol. 2007 Feb;177(2):521-5.PMID: 17222624
• Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer.
  Secin FP, Serio A, Bianco FJ Jr, Karanikolas NT, Kuroiwa K, Vickers A, Touijer K, Guillonneau B.Eur Urol. 2007 Mar;51(3):764-71. Epub 2006 Nov 3.PMID: 17098356
• Positive surgical margins and accessory pudendal artery preservation during laparoscopic radical prostatectomy.
  Secin FP, Karanikolas N, Kuroiwa K, Vickers A, Touijer K, Guillonneau B.Eur Urol. 2005 Nov;48(5):786-92; discussion 793. Epub 2005 Sep 8.PMID:16185810
• Anatomy of accessory pudendal arteries in laparoscopic radical prostatectomy.
  Secin FP, Karanikolas N, Touijer AK, Salamanca JI, Vickers AJ, Guillonneau B.J Urol. 2005 Aug;174(2):523-6; discussion 526.PMID:16006885

Book Chapters

• "Recent Advances in Endourology Vol.7. Endourological Management of Urogenital Carcinoma". Springer-Verlag Tokyo. Edition 2005. FP. Secin; N Karanikolas; K Touijer; B Guillonneau
• Bladder Cancer Vaccine Development in Bladder Cancer Diagnosis, Therapeutics and Management; Humana Press Inc  2010 Nicholas Karanikolas, Jonathan Coleman